DIABLO

diablo IAP-binding mitochondrial protein

Basic information

Region (hg38): 12:122207668-122226062

Links

ENSG00000184047NCBI:56616OMIM:605219HGNC:21528Uniprot:Q9NR28AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • autosomal dominant nonsyndromic hearing loss 64 (Moderate), mode of inheritance: AD
  • autosomal dominant nonsyndromic hearing loss (Supportive), mode of inheritance: AD
  • autosomal dominant nonsyndromic hearing loss 64 (Limited), mode of inheritance: AD
  • nonsyndromic genetic hearing loss (Limited), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Deafness, autosomal dominant 64ADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingAudiologic/Otolaryngologic21722859

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the DIABLO gene.

  • not_provided (83 variants)
  • not_specified (46 variants)
  • Autosomal_dominant_nonsyndromic_hearing_loss_64 (9 variants)
  • DIABLO-related_disorder (8 variants)
  • Nonsyndromic_genetic_hearing_loss (1 variants)
  • Autosomal_dominant_nonsyndromic_hearing_loss (1 variants)
  • Hearing_impairment (1 variants)
  • DIABLO-Related_Hearing_Loss (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the DIABLO gene is commonly pathogenic or not. These statistics are base on transcript: NM_001371333.1. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
14
clinvar
1
clinvar
15
missense
1
clinvar
57
clinvar
12
clinvar
70
nonsense
0
start loss
0
frameshift
1
clinvar
4
clinvar
5
splice donor/acceptor (+/-2bp)
1
clinvar
1
Total 0 2 62 26 1

Highest pathogenic variant AF is 0.00000410456

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
DIABLOprotein_codingprotein_codingENST00000443649 619872
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.000002570.5221257150331257480.000131
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-1.121611261.280.000007111529
Missense in Polyphen5748.7081.1702614
Synonymous-2.226545.91.420.00000239467
Loss of Function0.7641013.00.7716.46e-7158

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002390.000239
Ashkenazi Jewish0.00009920.0000992
East Asian0.000.00
Finnish0.0001920.000185
European (Non-Finnish)0.0001720.000167
Middle Eastern0.000.00
South Asian0.00006530.0000653
Other0.0001810.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Promotes apoptosis by activating caspases in the cytochrome c/Apaf-1/caspase-9 pathway. Acts by opposing the inhibitory activity of inhibitor of apoptosis proteins (IAP). Inhibits the activity of BIRC6/bruce by inhibiting its binding to caspases. Isoform 3 attenuates the stability and apoptosis- inhibiting activity of XIAP/BIRC4 by promoting XIAP/BIRC4 ubiquitination and degradation through the ubiquitin-proteasome pathway. Isoform 3 also disrupts XIAP/BIRC4 interacting with processed caspase-9 and promotes caspase-3 activation. Isoform 1 is defective in the capacity to down-regulate the XIAP/BIRC4 abundance. {ECO:0000269|PubMed:10929711, ECO:0000269|PubMed:14523016, ECO:0000269|PubMed:15200957}.;
Disease
DISEASE: Deafness, autosomal dominant, 64 (DFNA64) [MIM:614152]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:21722859}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Apoptosis - multiple species - Homo sapiens (human);Apoptosis - Homo sapiens (human);Apoptosis Modulation and Signaling;TNF alpha Signaling Pathway;Nanomaterial induced apoptosis;Apoptosis;Apoptotic Signaling Pathway;role of mitochondria in apoptotic signaling;Release of apoptotic factors from the mitochondria;SMAC-mediated dissociation of IAP:caspase complexes ;SMAC-mediated apoptotic response;Apoptotic factor-mediated response;Intrinsic Pathway for Apoptosis;Apoptosis;Programmed Cell Death;SMAC binds to IAPs ;TNFalpha;Caspase Cascade in Apoptosis;p75(NTR)-mediated signaling (Consensus)

Intolerance Scores

loftool
0.603
rvis_EVS
-0.21
rvis_percentile_EVS
38.58

Haploinsufficiency Scores

pHI
0.0999
hipred
Y
hipred_score
0.562
ghis
0.583

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.928

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Diablo
Phenotype
behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); normal phenotype; cellular phenotype; growth/size/body region phenotype;

Gene ontology

Biological process
apoptotic process;activation of cysteine-type endopeptidase activity involved in apoptotic process;extrinsic apoptotic signaling pathway via death domain receptors;intrinsic apoptotic signaling pathway in response to oxidative stress;activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c;positive regulation of apoptotic process;neuron apoptotic process;intrinsic apoptotic signaling pathway
Cellular component
mitochondrion;mitochondrial intermembrane space;cytosol;cytoplasmic side of plasma membrane;CD40 receptor complex
Molecular function
protein binding